
Hims & Hers Health targets $1B revenue by 2027 despite near-term margin and subscriber challenges.
Hims & Hers Health is rated a strong buy with an implied share price of $23.8, suggesting about 20% upside. The company expects revenue to reach at least $650 million in 2026 and $1 billion in 2027, driven mainly by international expansion and produc...

